Recent Updates
Recently added Catalysts
CTMX Positive Sentiment

CytomX Therapeutics to Present at the Barclays 27th Annual Global Healthcare Conference

Wednesday, March 5, 2025 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: CytomX Therapeutics, Inc. announced its participation in the Barclays 27th Annual Global Healthcare Conference. The presentation, led by CEO Sean McCarthy, is scheduled for March 12, 2025. A live webcast will be available on the company's website, and management will offer one-on-one meetings with registered investors during the event.
Price reaction · baseline $0.6528 (2025-03-04 close) · hit after-hours · 1 other CTMX headline(s) in the window, move may be shared
day 0 close · peak
-5.8%
day 1
-5.4%
day 3
+2.6%

Market Sentiment Analysis

POSITIVE FACTORS

  • CytomX Therapeutics is leading in masked, conditionally activated biologics.
  • CEO Sean McCarthy will present at a significant healthcare conference.
  • The company encourages engagement with investors through one-on-one meetings.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+53%
120-day peak, hindsight
Typical move
6.8%
average across 7 past catalysts
Cash runway
~54 mo
Minimal dilution risk
Lead asset
CX-2009
Phase 2 · Neoplasms

Full Press Release Details

SOUTH SAN FRANCISCO, Calif., March 05, 2025 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of masked, conditionally activated biologics, today announced that Sean McCarthy, D.Phil., chief executive officer and chairman, will present at the Barclays 27th Annual Global Healthcare Conference on Wednesday, March 12, 2025, at 3:00 p.m. ET.
A live webcast of the presentation will be available on the Events and Presentations page of CytomX’s website at www.cytomx.com. In addition, management will be available for one-on-one meetings with investors who are registered to attend the conferences.
About CytomX Therapeutics
SVP, Chief Financial Officer
Precision AQ (formerly Stern Investor Relations)

Frequently Asked Questions

When will CytomX present at the Barclays Conference?

CytomX will present on March 12, 2025, at 3:00 p.m. ET.

Who will present for CytomX at the conference?

Sean McCarthy, D.Phil., CEO and chairman, will present.

Where can I watch the CytomX conference presentation?

The presentation will be live streamed on CytomX's website.

Will CytomX management meet with investors?

Yes, management will meet with registered investors at the conference.

ShareAdd on Google
Tags: CTMX Viatris Investor Conferences Healthcare CytomX biologics healthcare conference Barclays Sean McCarthy
Last updated: Mar 5, 2025

Biotech snapshot

Cash runway
$330M liquidity · $6M/mo burn
~54 mo
Minimal dilution risk
Lead asset
CX-2009Phase 2
Neoplasms →

Catalyst track record

+53%
best trade around CTMX's most recent catalyst

Peak hindsight return over a 120-day window, across 7 tracked FDA/PDUFA catalysts for CTMX.

See every catalyst's timing & PoA →